|
Fusion gene ID: 8702 |
FusionGeneSummary for CSTB_PDE9A |
Fusion gene summary |
Fusion gene information | Fusion gene name: CSTB_PDE9A | Fusion gene ID: 8702 | Hgene | Tgene | Gene symbol | CSTB | PDE9A | Gene ID | 1476 | 5152 |
Gene name | cystatin B | phosphodiesterase 9A | |
Synonyms | CPI-B|CST6|EPM1|EPM1A|PME|STFB|ULD | HSPDE9A2 | |
Cytomap | 21q22.3 | 21q22.3 | |
Type of gene | protein-coding | protein-coding | |
Description | cystatin-Bcystatin B (stefin B)liver thiol proteinase inhibitor | high affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9ACGMP-specific 3',5'-cyclic phosphodiesterase type 9phosphodiesterase PDE9A21 | |
Modification date | 20180523 | 20180519 | |
UniProtAcc | P04080 | O76083 | |
Ensembl transtripts involved in fusion gene | ENST00000291568, | ENST00000335512, ENST00000539837, ENST00000470987, ENST00000291539, ENST00000398236, ENST00000398229, ENST00000398234, ENST00000398232, ENST00000398227, ENST00000398225, ENST00000380328, ENST00000328862, ENST00000335440, ENST00000398224, ENST00000349112, | |
Fusion gene scores | * DoF score | 4 X 4 X 2=32 | 5 X 4 X 5=100 |
# samples | 4 | 5 | |
** MAII score | log2(4/32*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(5/100*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: CSTB [Title/Abstract] AND PDE9A [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | CSTB | GO:0010466 | negative regulation of peptidase activity | 6203523 |
Hgene | CSTB | GO:0045861 | negative regulation of proteolysis | 3488317 |
Tgene | PDE9A | GO:0046068 | cGMP metabolic process | 9624146 |
Tgene | PDE9A | GO:0046069 | cGMP catabolic process | 25799991 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | SARC | TCGA-3B-A9HO-01A | CSTB | chr21 | 45196085 | - | PDE9A | chr21 | 44188298 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000291568 | ENST00000335512 | CSTB | chr21 | 45196085 | - | PDE9A | chr21 | 44188298 | + |
In-frame | ENST00000291568 | ENST00000539837 | CSTB | chr21 | 45196085 | - | PDE9A | chr21 | 44188298 | + |
5CDS-3UTR | ENST00000291568 | ENST00000470987 | CSTB | chr21 | 45196085 | - | PDE9A | chr21 | 44188298 | + |
5CDS-3UTR | ENST00000291568 | ENST00000291539 | CSTB | chr21 | 45196085 | - | PDE9A | chr21 | 44188298 | + |
5CDS-3UTR | ENST00000291568 | ENST00000398236 | CSTB | chr21 | 45196085 | - | PDE9A | chr21 | 44188298 | + |
5CDS-3UTR | ENST00000291568 | ENST00000398229 | CSTB | chr21 | 45196085 | - | PDE9A | chr21 | 44188298 | + |
5CDS-3UTR | ENST00000291568 | ENST00000398234 | CSTB | chr21 | 45196085 | - | PDE9A | chr21 | 44188298 | + |
5CDS-3UTR | ENST00000291568 | ENST00000398232 | CSTB | chr21 | 45196085 | - | PDE9A | chr21 | 44188298 | + |
5CDS-3UTR | ENST00000291568 | ENST00000398227 | CSTB | chr21 | 45196085 | - | PDE9A | chr21 | 44188298 | + |
5CDS-3UTR | ENST00000291568 | ENST00000398225 | CSTB | chr21 | 45196085 | - | PDE9A | chr21 | 44188298 | + |
5CDS-3UTR | ENST00000291568 | ENST00000380328 | CSTB | chr21 | 45196085 | - | PDE9A | chr21 | 44188298 | + |
5CDS-3UTR | ENST00000291568 | ENST00000328862 | CSTB | chr21 | 45196085 | - | PDE9A | chr21 | 44188298 | + |
5CDS-3UTR | ENST00000291568 | ENST00000335440 | CSTB | chr21 | 45196085 | - | PDE9A | chr21 | 44188298 | + |
5CDS-3UTR | ENST00000291568 | ENST00000398224 | CSTB | chr21 | 45196085 | - | PDE9A | chr21 | 44188298 | + |
5CDS-3UTR | ENST00000291568 | ENST00000349112 | CSTB | chr21 | 45196085 | - | PDE9A | chr21 | 44188298 | + |
Top |
FusionProtFeatures for CSTB_PDE9A |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
CSTB | PDE9A |
This is an intracellular thiol proteinase inhibitor.Tightly binding reversible inhibitor of cathepsins L, H and B. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | >PDE9A | chr21:45196085 | chr21:44188298 | ENST00000291539 | + | 14 | 20 | 512_513 | 452 | 594 | Nucleotide binding | cGMP |
Tgene | >PDE9A | chr21:45196085 | chr21:44188298 | ENST00000328862 | + | 13 | 19 | 512_513 | 426 | 568 | Nucleotide binding | cGMP |
Tgene | >PDE9A | chr21:45196085 | chr21:44188298 | ENST00000335440 | + | 11 | 17 | 512_513 | 350 | 492 | Nucleotide binding | cGMP |
Tgene | >PDE9A | chr21:45196085 | chr21:44188298 | ENST00000335512 | + | 13 | 19 | 512_513 | 392 | 534 | Nucleotide binding | cGMP |
Tgene | >PDE9A | chr21:45196085 | chr21:44188298 | ENST00000349112 | + | 10 | 16 | 512_513 | 324 | 466 | Nucleotide binding | cGMP |
Tgene | >PDE9A | chr21:45196085 | chr21:44188298 | ENST00000380328 | + | 13 | 19 | 512_513 | 399 | 541 | Nucleotide binding | cGMP |
Tgene | >PDE9A | chr21:45196085 | chr21:44188298 | ENST00000398224 | + | 11 | 17 | 512_513 | 325 | 467 | Nucleotide binding | cGMP |
Tgene | >PDE9A | chr21:45196085 | chr21:44188298 | ENST00000398225 | + | 13 | 19 | 512_513 | 411 | 553 | Nucleotide binding | cGMP |
Tgene | >PDE9A | chr21:45196085 | chr21:44188298 | ENST00000398227 | + | 9 | 15 | 312_316 | 292 | 434 | Nucleotide binding | cGMP |
Tgene | >PDE9A | chr21:45196085 | chr21:44188298 | ENST00000398227 | + | 9 | 15 | 512_513 | 292 | 434 | Nucleotide binding | cGMP |
Tgene | >PDE9A | chr21:45196085 | chr21:44188298 | ENST00000398229 | + | 10 | 16 | 512_513 | 318 | 460 | Nucleotide binding | cGMP |
Tgene | >PDE9A | chr21:45196085 | chr21:44188298 | ENST00000398232 | + | 12 | 18 | 512_513 | 385 | 527 | Nucleotide binding | cGMP |
Tgene | >PDE9A | chr21:45196085 | chr21:44188298 | ENST00000398234 | + | 12 | 18 | 512_513 | 351 | 493 | Nucleotide binding | cGMP |
Tgene | >PDE9A | chr21:45196085 | chr21:44188298 | ENST00000398236 | + | 12 | 18 | 512_513 | 366 | 508 | Nucleotide binding | cGMP |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | >CSTB | chr21:45196085 | chr21:44188298 | ENST00000291568 | - | 1 | 3 | 46_50 | 22 | 99 | Motif | Note=Secondary area of contact |
Tgene | PDE9A | chr21:45196085 | chr21:44188298 | ENST00000291539 | + | 14 | 20 | 236_557 | 452 | 594 | Domain | PDEase |
Tgene | PDE9A | chr21:45196085 | chr21:44188298 | ENST00000328862 | + | 13 | 19 | 236_557 | 426 | 568 | Domain | PDEase |
Tgene | PDE9A | chr21:45196085 | chr21:44188298 | ENST00000335440 | + | 11 | 17 | 236_557 | 350 | 492 | Domain | PDEase |
Tgene | PDE9A | chr21:45196085 | chr21:44188298 | ENST00000335512 | + | 13 | 19 | 236_557 | 392 | 534 | Domain | PDEase |
Tgene | PDE9A | chr21:45196085 | chr21:44188298 | ENST00000349112 | + | 10 | 16 | 236_557 | 324 | 466 | Domain | PDEase |
Tgene | PDE9A | chr21:45196085 | chr21:44188298 | ENST00000380328 | + | 13 | 19 | 236_557 | 399 | 541 | Domain | PDEase |
Tgene | PDE9A | chr21:45196085 | chr21:44188298 | ENST00000398224 | + | 11 | 17 | 236_557 | 325 | 467 | Domain | PDEase |
Tgene | PDE9A | chr21:45196085 | chr21:44188298 | ENST00000398225 | + | 13 | 19 | 236_557 | 411 | 553 | Domain | PDEase |
Tgene | PDE9A | chr21:45196085 | chr21:44188298 | ENST00000398227 | + | 9 | 15 | 236_557 | 292 | 434 | Domain | PDEase |
Tgene | PDE9A | chr21:45196085 | chr21:44188298 | ENST00000398229 | + | 10 | 16 | 236_557 | 318 | 460 | Domain | PDEase |
Tgene | PDE9A | chr21:45196085 | chr21:44188298 | ENST00000398232 | + | 12 | 18 | 236_557 | 385 | 527 | Domain | PDEase |
Tgene | PDE9A | chr21:45196085 | chr21:44188298 | ENST00000398234 | + | 12 | 18 | 236_557 | 351 | 493 | Domain | PDEase |
Tgene | PDE9A | chr21:45196085 | chr21:44188298 | ENST00000398236 | + | 12 | 18 | 236_557 | 366 | 508 | Domain | PDEase |
Tgene | PDE9A | chr21:45196085 | chr21:44188298 | ENST00000291539 | + | 14 | 20 | 312_316 | 452 | 594 | Nucleotide binding | cGMP |
Tgene | PDE9A | chr21:45196085 | chr21:44188298 | ENST00000328862 | + | 13 | 19 | 312_316 | 426 | 568 | Nucleotide binding | cGMP |
Tgene | PDE9A | chr21:45196085 | chr21:44188298 | ENST00000335440 | + | 11 | 17 | 312_316 | 350 | 492 | Nucleotide binding | cGMP |
Tgene | PDE9A | chr21:45196085 | chr21:44188298 | ENST00000335512 | + | 13 | 19 | 312_316 | 392 | 534 | Nucleotide binding | cGMP |
Tgene | PDE9A | chr21:45196085 | chr21:44188298 | ENST00000349112 | + | 10 | 16 | 312_316 | 324 | 466 | Nucleotide binding | cGMP |
Tgene | PDE9A | chr21:45196085 | chr21:44188298 | ENST00000380328 | + | 13 | 19 | 312_316 | 399 | 541 | Nucleotide binding | cGMP |
Tgene | PDE9A | chr21:45196085 | chr21:44188298 | ENST00000398224 | + | 11 | 17 | 312_316 | 325 | 467 | Nucleotide binding | cGMP |
Tgene | PDE9A | chr21:45196085 | chr21:44188298 | ENST00000398225 | + | 13 | 19 | 312_316 | 411 | 553 | Nucleotide binding | cGMP |
Tgene | PDE9A | chr21:45196085 | chr21:44188298 | ENST00000398229 | + | 10 | 16 | 312_316 | 318 | 460 | Nucleotide binding | cGMP |
Tgene | PDE9A | chr21:45196085 | chr21:44188298 | ENST00000398232 | + | 12 | 18 | 312_316 | 385 | 527 | Nucleotide binding | cGMP |
Tgene | PDE9A | chr21:45196085 | chr21:44188298 | ENST00000398234 | + | 12 | 18 | 312_316 | 351 | 493 | Nucleotide binding | cGMP |
Tgene | PDE9A | chr21:45196085 | chr21:44188298 | ENST00000398236 | + | 12 | 18 | 312_316 | 366 | 508 | Nucleotide binding | cGMP |
Top |
FusionGeneSequence for CSTB_PDE9A |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
>In-frame_CSTB_ENST00000291568_chr21_45196085_-_PDE9A_ENST00000335512_chr21_44188298_+_164aa MMCGAPSATQPATAETQHIADQLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFV >In-frame_CSTB_ENST00000291568_chr21_45196085_-_PDE9A_ENST00000539837_chr21_44188298_+_164aa MMCGAPSATQPATAETQHIADQLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFV |
* Fusion transcript sequences (only coding sequence (CDS) region). |
>In-frame_CSTB_ENST00000291568_chr21_45196085_-_PDE9A_ENST00000335512_chr21_44188298_+_492nt ATGATGTGCGGGGCGCCCTCCGCCACGCAGCCGGCCACCGCCGAGACCCAGCACATCGCCGACCAGCTGAAGATGATTTTGATAAAATGC TGTGATATCTCTAACGAGGTCCGTCCAATGGAAGTCGCAGAGCCTTGGGTGGACTGTTTATTAGAGGAATATTTTATGCAGAGCGACCGT GAGAAGTCAGAAGGCCTTCCTGTGGCACCGTTCATGGACCGAGACAAAGTGACCAAGGCCACAGCCCAGATTGGGTTCATCAAGTTTGTC CTGATCCCAATGTTTGAAACAGTGACCAAGCTCTTCCCCATGGTTGAGGAGATCATGCTGCAGCCACTTTGGGAATCCCGAGATCGCTAC GAGGAGCTGAAGCGGATAGATGACGCCATGAAAGAGTTACAGAAGAAGACTGACAGCTTGACGTCTGGGGCCACCGAGAAGTCCAGAGAG >In-frame_CSTB_ENST00000291568_chr21_45196085_-_PDE9A_ENST00000539837_chr21_44188298_+_492nt ATGATGTGCGGGGCGCCCTCCGCCACGCAGCCGGCCACCGCCGAGACCCAGCACATCGCCGACCAGCTGAAGATGATTTTGATAAAATGC TGTGATATCTCTAACGAGGTCCGTCCAATGGAAGTCGCAGAGCCTTGGGTGGACTGTTTATTAGAGGAATATTTTATGCAGAGCGACCGT GAGAAGTCAGAAGGCCTTCCTGTGGCACCGTTCATGGACCGAGACAAAGTGACCAAGGCCACAGCCCAGATTGGGTTCATCAAGTTTGTC CTGATCCCAATGTTTGAAACAGTGACCAAGCTCTTCCCCATGGTTGAGGAGATCATGCTGCAGCCACTTTGGGAATCCCGAGATCGCTAC GAGGAGCTGAAGCGGATAGATGACGCCATGAAAGAGTTACAGAAGAAGACTGACAGCTTGACGTCTGGGGCCACCGAGAAGTCCAGAGAG |
* Fusion transcript sequences (Full-length transcript). |
>In-frame_CSTB_ENST00000291568_chr21_45196085_-_PDE9A_ENST00000335512_chr21_44188298_+_884nt CGCGTCCCTTCTTGCGGGGCCACCGCGACCCCGCAGGGGACTCCGAAGCCAAAGTGCCTCCTCCCCGCCCCTTGGTTCCGCCCGCGCGTC ACGTGACCCCAGCGCCTACTTGGGCTGAGGAGCCGCCGCGTCCCCTCGCCGAGTCCCCTCGCCAGATTCCCTCCGTCGCCGCCAAGATGA TGTGCGGGGCGCCCTCCGCCACGCAGCCGGCCACCGCCGAGACCCAGCACATCGCCGACCAGCTGAAGATGATTTTGATAAAATGCTGTG ATATCTCTAACGAGGTCCGTCCAATGGAAGTCGCAGAGCCTTGGGTGGACTGTTTATTAGAGGAATATTTTATGCAGAGCGACCGTGAGA AGTCAGAAGGCCTTCCTGTGGCACCGTTCATGGACCGAGACAAAGTGACCAAGGCCACAGCCCAGATTGGGTTCATCAAGTTTGTCCTGA TCCCAATGTTTGAAACAGTGACCAAGCTCTTCCCCATGGTTGAGGAGATCATGCTGCAGCCACTTTGGGAATCCCGAGATCGCTACGAGG AGCTGAAGCGGATAGATGACGCCATGAAAGAGTTACAGAAGAAGACTGACAGCTTGACGTCTGGGGCCACCGAGAAGTCCAGAGAGAGAA GCAGAGATGTGAAAAACAGTGAAGGAGACTGTGCCTGAGGAAAGCGGGGGGCGTGGCTGCAGTTCTGGACGGGCTGGCCGAGCTGCGCGG GATCCTTGTGCAGGGAAGAGCTGCCCTGGGCACCTGGCACCACAAGACCATGTTTTCTAAGAACCATTTTGTTCACTGATACAAAAAAAA >In-frame_CSTB_ENST00000291568_chr21_45196085_-_PDE9A_ENST00000539837_chr21_44188298_+_881nt CGCGTCCCTTCTTGCGGGGCCACCGCGACCCCGCAGGGGACTCCGAAGCCAAAGTGCCTCCTCCCCGCCCCTTGGTTCCGCCCGCGCGTC ACGTGACCCCAGCGCCTACTTGGGCTGAGGAGCCGCCGCGTCCCCTCGCCGAGTCCCCTCGCCAGATTCCCTCCGTCGCCGCCAAGATGA TGTGCGGGGCGCCCTCCGCCACGCAGCCGGCCACCGCCGAGACCCAGCACATCGCCGACCAGCTGAAGATGATTTTGATAAAATGCTGTG ATATCTCTAACGAGGTCCGTCCAATGGAAGTCGCAGAGCCTTGGGTGGACTGTTTATTAGAGGAATATTTTATGCAGAGCGACCGTGAGA AGTCAGAAGGCCTTCCTGTGGCACCGTTCATGGACCGAGACAAAGTGACCAAGGCCACAGCCCAGATTGGGTTCATCAAGTTTGTCCTGA TCCCAATGTTTGAAACAGTGACCAAGCTCTTCCCCATGGTTGAGGAGATCATGCTGCAGCCACTTTGGGAATCCCGAGATCGCTACGAGG AGCTGAAGCGGATAGATGACGCCATGAAAGAGTTACAGAAGAAGACTGACAGCTTGACGTCTGGGGCCACCGAGAAGTCCAGAGAGAGAA GCAGAGATGTGAAAAACAGTGAAGGAGACTGTGCCTGAGGAAAGCGGGGGGCGTGGCTGCAGTTCTGGACGGGCTGGCCGAGCTGCGCGG GATCCTTGTGCAGGGAAGAGCTGCCCTGGGCACCTGGCACCACAAGACCATGTTTTCTAAGAACCATTTTGTTCACTGATACAAAAAAAA |
Top |
FusionGenePPI for CSTB_PDE9A |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
CSTB | VHL, CTSB, CTSH, CST3, SPRY2, RAD21, CUL3, DCUN1D1, MAT2A, NUDC, FLNB, SEC24A, ECT2, CFTR, BAG3, DPP7, SARNP, ABCE1, PCMT1, GSTT1, PDCD6, HIST1H3E, MCM2, DUSP13 | PDE9A | TRIM32, PHYHIPL, PDE9A, CLK1, CRY2, LMO2, SULT1E1, LAGE3, BAG3, GORASP2, TRPV6, KRTAP9-2, UTP23, NAA38, KRTAP4-2, KRTAP10-8, KRTAP10-3, NOTCH2NL, C9orf106, UNC119, TFAP4, C12orf75, PRKG2, RSPRY1, NPHP3 |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for CSTB_PDE9A |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for CSTB_PDE9A |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | CSTB | C0751785 | Unverricht-Lundborg Syndrome | 3 | CTD_human;ORPHANET;UNIPROT |
Hgene | CSTB | C0027626 | Neoplasm Invasiveness | 2 | CTD_human |
Hgene | CSTB | C0017636 | Glioblastoma | 1 | CTD_human |
Hgene | CSTB | C0025286 | Meningioma | 1 | CTD_human |
Hgene | CSTB | C0279626 | Squamous cell carcinoma of esophagus | 1 | CTD_human |
Tgene | PDE9A | C0005586 | Bipolar Disorder | 1 | PSYGENET |